Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Comparing Five Comorbidity Indices to Predict Mortality in Chronic Kidney Disease: A Retrospective Cohort Study.

McArthur E, Bota SE, Sood MM, Nesrallah GE, Kim SJ, Garg AX, Dixon SN.

Can J Kidney Health Dis. 2018 Oct 15;5:2054358118805418. doi: 10.1177/2054358118805418. eCollection 2018.

2.

Hospital case volume and clinical outcomes in critically ill patients with acute kidney injury treated with dialysis.

Chimunda T, Silver SA, Kuwornu JP, Li L, Nash DM, Dixon SN, Adhikari NKJ, Acedillo RR, Harel Z, Kitchlu A, Garg AX, Bell CM, Sood MM, Kim JS, Wald R.

J Crit Care. 2018 Dec;48:276-282. doi: 10.1016/j.jcrc.2018.08.024. Epub 2018 Sep 5.

PMID:
30248649
3.

Is the Kidney Donor Risk Index a Useful Tool in Non-US Patients?

Young A, Knoll GA, McArthur E, Dixon SN, Garg AX, Lok CE, Lam NN, Kim SJ.

Can J Kidney Health Dis. 2018 Jul 27;5:2054358118791148. doi: 10.1177/2054358118791148. eCollection 2018.

4.

Home Palliative Service Utilization and Care Trajectory Among Ontario Residents Dying on Chronic Dialysis.

Nesrallah GE, Dixon SN, MacKinnon M, Jassal SV, Bota SE, Dirk JS, Arthurs E, Blake PG, Sood MM, Garg AX, Davison SN.

Can J Kidney Health Dis. 2018 Jul 24;5:2054358118783761. doi: 10.1177/2054358118783761. eCollection 2018.

5.

Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study.

Chanchlani R, Kim SJ, Dixon SN, Jassal V, Banh T, Borges K, Vasilevska-Ristovska J, Paterson JM, Ng V, Dipchand A, Solomon M, Hebert D, Parekh RS.

Nephrol Dial Transplant. 2019 Mar 1;34(3):524-531. doi: 10.1093/ndt/gfy213.

PMID:
30060206
6.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

7.

Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study.

Fleet JL, Dixon SN, Kuwornu PJ, Dev VK, Montero-Odasso M, Burneo J, Garg AX.

PLoS One. 2018 Mar 14;13(3):e0193134. doi: 10.1371/journal.pone.0193134. eCollection 2018.

8.

Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.

Habbous S, McArthur E, Dixon SN, McKenzie S, Garcia-Ochoa C, Lam NN, Lentine KL, Dipchand C, Litchfield K, Begen MA, Sarma S, Garg AX.

Transplantation. 2018 Jul;102(7):e345-e353. doi: 10.1097/TP.0000000000002159.

PMID:
29538259
9.

Positive Predictive Values of International Classification of Diseases, 10th Revision Coding Algorithms to Identify Patients With Autosomal Dominant Polycystic Kidney Disease.

Kalatharan V, Pei Y, Clemens KK, McTavish RK, Dixon SN, Rochon M, Nash DM, Jain A, Sarma S, Zaleski A, Lum A, Garg AX.

Can J Kidney Health Dis. 2016 Dec 14;3:2054358116679130. doi: 10.1177/2054358116679130. eCollection 2016.

10.

Variation in Access to Kidney Transplantation Across Renal Programs in Ontario, Canada.

Naylor KL, Dixon SN, Garg AX, Kim SJ, Blake PG, Nesrallah GE, McCallum MK, D'Antonio C, Li AH, Knoll GA.

Am J Transplant. 2017 Jun;17(6):1585-1593. doi: 10.1111/ajt.14133. Epub 2017 Jan 9.

11.

Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.

Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):95-104. doi: 10.2215/CJN.05990616. Epub 2016 Dec 29.

12.

Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.

Qirjazi E, McArthur E, Nash DM, Dixon SN, Weir MA, Vasudev A, Jandoc R, Gula LJ, Oliver MJ, Wald R, Garg AX.

PLoS One. 2016 Aug 11;11(8):e0160768. doi: 10.1371/journal.pone.0160768. eCollection 2016.

13.

Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.

Oliver MJ, Al-Jaishi AA, Dixon SN, Perl J, Jain AK, Lavoie SD, Nash DM, Paterson JM, Lok CE, Quinn RR.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1606-14. doi: 10.2215/CJN.10130915. Epub 2016 Jul 27.

14.

The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation.

Young A, Dixon SN, Knoll GA, Garg AX, Lok CE, Lam NN, Kim SJ.

Can J Kidney Health Dis. 2016 Mar 24;3:15. doi: 10.1186/s40697-016-0106-9. eCollection 2016.

15.

Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.

Trac MH, McArthur E, Jandoc R, Dixon SN, Nash DM, Hackam DG, Garg AX.

CMAJ. 2016 Apr 19;188(7):E120-E129. doi: 10.1503/cmaj.150901. Epub 2016 Feb 22.

16.

The hypoglycemic risk of glyburide (glibenclamide) compared with modified-release gliclazide.

Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX.

Can J Diabetes. 2015 Nov;39 Suppl 4:32-40. doi: 10.1016/j.jcjd.2015.09.087.

PMID:
26541489
17.

Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.

Weir MA, Fleet JL, Dixon SN, Jain AK, Oliver M, Wald R, McIntyre C, Garg AX.

Blood Purif. 2015;40(3):232-42. doi: 10.1159/000438821. Epub 2015 Sep 18.

PMID:
26382240
18.

The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.

Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX.

Can J Diabetes. 2015 Aug;39(4):308-16. doi: 10.1016/j.jcjd.2015.01.001. Epub 2015 Mar 31.

PMID:
25840942
19.

Falls and fractures with atypical antipsychotic medication use: a population-based cohort study.

Fraser LA, Liu K, Naylor KL, Hwang YJ, Dixon SN, Shariff SZ, Garg AX.

JAMA Intern Med. 2015 Mar;175(3):450-2. doi: 10.1001/jamainternmed.2014.6930. No abstract available.

PMID:
25581312
20.

β-Blocker dialyzability and mortality in older patients receiving hemodialysis.

Weir MA, Dixon SN, Fleet JL, Roberts MA, Hackam DG, Oliver MJ, Suri RS, Quinn RR, Ozair S, Beyea MM, Kitchlu A, Garg AX.

J Am Soc Nephrol. 2015 Apr;26(4):987-96. doi: 10.1681/ASN.2014040324. Epub 2014 Oct 30.

21.

Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.

Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, Shariff SZ, Pannu N, Nash DM, Rehman F, Garg AX.

Ann Intern Med. 2014 Aug 19;161(4):242-8. doi: 10.7326/M13-2796.

PMID:
25133360
22.

Predictors of progression to chronic dialysis in survivors of severe acute kidney injury: a competing risk study.

Harel Z, Bell CM, Dixon SN, McArthur E, James MT, Garg AX, Harel S, Silver S, Wald R.

BMC Nephrol. 2014 Jul 10;15:114. doi: 10.1186/1471-2369-15-114.

23.

Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study.

Dev V, Dixon SN, Fleet JL, Gandhi S, Gomes T, Harel Z, Jain AK, Shariff SZ, Tawadrous D, Weir MA, Garg AX.

BMC Nephrol. 2014 May 10;15:79. doi: 10.1186/1471-2369-15-79.

24.

Complications of daytime elective laparoscopic cholecystectomies performed by surgeons who operated the night before.

Vinden C, Nash DM, Rangrej J, Shariff SZ, Dixon SN, Jain AK, Garg AX.

JAMA. 2013 Nov 6;310(17):1837-41. doi: 10.1001/jama.2013.280372.

PMID:
24193081
25.

Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium.

Thomson BK, Dixon SN, Huang SH, Leitch RE, Suri RS, Chan CT, Lindsay RM.

Hemodial Int. 2013 Oct;17(4):576-85. doi: 10.1111/hdi.12056. Epub 2013 Jun 18.

PMID:
23782770
26.

Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data.

Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF.

Am J Nephrol. 2013;37(5):434-42. doi: 10.1159/000350377. Epub 2013 Apr 17.

27.

Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes.

Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, Garg AX.

BMC Nephrol. 2013 Apr 5;14:81. doi: 10.1186/1471-2369-14-81.

28.

Adjusted inference procedures for the interobserver agreement in twin studies.

Dixon SN, Donner A, Shoukri MM.

Stat Methods Med Res. 2016 Aug;25(4):1260-71. doi: 10.1177/0962280213476771. Epub 2013 Mar 12.

PMID:
23487017
29.

Event-weighted proportional hazards modelling for recurrent gap time data.

Darlington GA, Dixon SN.

Stat Med. 2013 Jan 15;32(1):124-30. doi: 10.1002/sim.5522. Epub 2012 Jul 24.

PMID:
22825881
30.

Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Norcross EW, Sanders ME, Moore QC 3rd, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

31.

A competing risks model for correlated data based on the subdistribution hazard.

Dixon SN, Darlington GA, Desmond AF.

Lifetime Data Anal. 2011 Oct;17(4):473-95. doi: 10.1007/s10985-011-9198-9. Epub 2011 May 21.

PMID:
21603882
32.

"Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza a evolution.

Thangavel RR, Reed A, Norcross EW, Dixon SN, Marquart ME, Stray SJ.

Virol J. 2011 Apr 18;8:180. doi: 10.1186/1743-422X-8-180.

33.

Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2661-6.

34.
35.

An enzyme immunoassay for the anabolic agent zeranol.

Patel PJ, Dixon SN.

Food Addit Contam. 1989 Jan-Mar;6(1):91-101.

PMID:
2643539
36.
38.
39.

An improved radioimmunoassay for the anabolic agent hexoestrol, using a monoclonal antibody.

Carter AP, Cottingham JD, Dixon SN, Heitzman RJ.

J Vet Pharmacol Ther. 1985 Dec;8(4):362-7.

PMID:
3005606
40.

Preparation and properties of monoclonal antibodies to the anabolic agent zeranol.

Carter AP, Dixon SN, Bew MH.

J Vet Pharmacol Ther. 1984 Mar;7(1):17-21.

PMID:
6708163
41.

The efficacy, mode of action and safety of non-steroidal non-antimicrobial growth promoters.

Dixon SN.

Vet Res Commun. 1983 Dec;7(1-4):51-7. Review. No abstract available.

PMID:
6320520
43.

Proteins in the uterine secretions of the cow.

Dixon SN, Gibbons RA.

J Reprod Fertil. 1979 May;56(1):119-27.

PMID:
469832
44.

Uterine secretions in the cow and sheep.

Gibbons RA, Dixon SN, Roberts GP.

Biochem Soc Trans. 1977;5(2):452-4. No abstract available.

PMID:
20367
45.

Manganese metabolism in cows and goats.

Gibbons RA, Dixon SN, Hallis K, Russell AM, Sansom BF, Symonds HW.

Biochim Biophys Acta. 1976 Aug 24;444(1):1-10.

PMID:
60137
46.

Glycopeptides from bovine liver basement membrane and plasma membrane.

Gibbons RA, Dixon SN, Sellwood R.

Eur J Biochem. 1976 Jul 1;66(2):243-50.

47.

Iron dynamics in the ruminant.

Gibbons RA, Dixon SN, Russell AM, Sansom BF.

Biochim Biophys Acta. 1976 Jun 23;437(1):301-4.

PMID:
949508
48.

Chemical and physical characteristics of the macromolecular components of the cervical mucus from cows after synchronization of oestrus with melengestrol actate.

Gibbons RA, Boyd LJ, Dixon SN, Parker J, Sellwood R, Tasker JB.

J Reprod Fertil. 1973 Dec;35(3):469-76. No abstract available.

PMID:
4796772
50.

Characterization of a glycoprotein in the cyst fluid of Cysticercus tenuicollis from the goat.

Dixon SN, Gibbons R, Parker J, Sellwood R.

Int J Parasitol. 1973 May;3(3):419-24. No abstract available.

PMID:
4200009

Supplemental Content

Loading ...
Support Center